Clinical Trial

Role of SPECT/CT of Bone Scan in Charactarization of Bone Lesions

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This observational study aims to assess the diagnostic value of SPECT/CT of 99mTc-MDP bone scintigraphy in differentiating begnin from malignant bone lesions. The main question it aims to answer is: ●Can SPECT/CT-derived quantitative parameters (SUVmax, SUVmean) accurately differentiate between begnin and malignant bone lesions in clinical settings? Final diagnostic impression: confirmed by biopsy (if available), or through multidisciplinary radiologic-clinical correlation
Trial Details
NCT Number NCT07248033
Lead Sponsor MennaTalla Saber Sabet Mohamed
Conditions Bone Lesions
Enrollment 120 participants
Start Date 2025-11
Primary Completion 2026-11 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-11-25